The Effects of Acute Weight Gain and Acute Calorie Deprivation on Marrow Adipose Tissue
1 other identifier
interventional
28
1 country
1
Brief Summary
Marrow adipocytes have been identified as a component of the bone marrow micro-environment. Evidence exists suggesting that marrow fat plays an important physiologic role in both bone mineral and energy metabolism in humans. The investigators will study the effects of acute weight gain and acute nutritional deprivation on energy homeostasis and bone mineral metabolism by examining marrow adiposity, peripheral fat depots and bone microarchitecture. The study will include two ten day inpatient study visits. Participants will eat a high calorie diet for 10 days, followed by a 13-18 day stabilization period at home, and then return for a ten day fast.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable healthy
Started Nov 2015
Longer than P75 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 16, 2015
CompletedFirst Posted
Study publicly available on registry
June 26, 2015
CompletedStudy Start
First participant enrolled
November 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2018
CompletedJanuary 4, 2023
December 1, 2022
2.4 years
June 16, 2015
December 30, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Marrow adiposity will be measured using magnetic resonance spectroscopy
Marrow adipose tissue measurement of the spine and hip
Change from baseline marrow adipose tissue after high-calorie diet and after fast (35 days)
Study Arms (1)
10 day overfeeding/fasting
OTHER10 day high calorie diet followed by a 10 day fast
Interventions
Eligibility Criteria
You may qualify if:
- Men and women, ages 21-45 years
- % of ideal body weight as defined by the 1983 Metropolitan Life Insurance Height and Weight Tables
- Normal thyroid function
- Regular menses (women) - Female subjects will start the study within 1 week of Day 1 of their menstrual period
- Normal transaminase levels (AST/ALT)
You may not qualify if:
- Any disease known to affect bone metabolism, including untreated thyroid dysfunction, Cushing's syndrome, or renal failure
- Any medication known to affect bone metabolism -- including systemic steroids or immunosuppressants -- within three months of the study, excluding estrogen and progestins. Patients receiving depot medroxyprogesterone (Depo-Provera) will be excluded from participating for six months after their last injections. Bisphosphonates must have been discontinued for at least one year before participation
- Serum potassium \<3.0 meq/L
- History of eating disorder
- Pregnant and/or breastfeeding (women)
- Diabetes mellitus
- Active substance abuse, including alcohol
- Contraindications to MRI: cardiac pacemaker, metal implants, claustrophobia
- History of chemotherapy or radiation therapy
- History of a bleeding disorder or use of anti-platelet medications
- Allergy to allopurinol
- The study physician feels that the subject may not be able to safely complete the study or may place themselves at risk by undergoing the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Massachusettes General Hospital
Boston, Massachusetts, 02114, United States
Related Publications (1)
Colling C, Bredella MA, Fazeli PK, Pachon-Pena G, Singh RJ, Rosen CJ, Miller KK. Changes in serum cortisol levels after 10 days of overfeeding and fasting. Am J Physiol Endocrinol Metab. 2023 Jun 1;324(6):E506-E513. doi: 10.1152/ajpendo.00181.2022. Epub 2023 Apr 13.
PMID: 37053050DERIVED
MeSH Terms
Interventions
Study Officials
- PRINCIPAL INVESTIGATOR
Anne Klibanski, MD
MGH/Harvard Medical School
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief, Neuroendocrine Unit
Study Record Dates
First Submitted
June 16, 2015
First Posted
June 26, 2015
Study Start
November 1, 2015
Primary Completion
April 1, 2018
Study Completion
April 1, 2018
Last Updated
January 4, 2023
Record last verified: 2022-12